Daclizumab, a humanised monoclonal antibody to the interleukin 2 receptor (CD25), for the treatment of moderately to severely active ulcerative colitis: a randomised, double blind, placebo controlled, dose ranging trial
| Image |  |
|---|---|
| Description | scientific article published on 7 April 2006 |
| Author/s |
author: Paul Rutgeerts Brian G. Feagan William Jeffery Sandborn Stephan R. Targan |
| Publication date | April 7, 2006 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |